ANXA6 and head and neck squamous cell carcinoma: To further evaluate the expression of ANXA6, IHC staining was conducted on 78 HNSCC cases with complete clinical data and follow-up (Fig. 1D; Table 1), showing that it was significantly higher in the LM group compared with the NLM and NAT groups.